Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Commercial
Financial
Financial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Financial
Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals
Biospace News
-
July 18, 2019
Financial
Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results
Financial
The Medicines Company to Announce Second Quarter 2019 Financial Results on July 24
Financial
Cytori Will Become Plus Therapeutics, Inc.
Financial
Kite Announces Plans to Bolster Industry-Leading Cell Therapy Manufacturing Capabilities With New Viral Vector Facility
Financial
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results –...
Biospace News
-
July 15, 2019
0
Financial
NovaBay Pharmaceuticals Issues Letter to Stockholders
Biospace News
-
July 15, 2019
0
Financial
Poxel Reports Financial Update for Cash and Revenue for the Second...
Biospace News
-
July 15, 2019
0
Financial
Biosimilars Struggle to Gain Market Share in the U.S., Analysis Shows
Biospace News
-
July 12, 2019
0
Financial
Indivior Raises FY 2019 Net Revenue and Net Income Guidance; Cash...
Biospace News
-
July 11, 2019
0
1
2
3
...
76
Page 1 of 76
- Advertisement -
MOST POPULAR
X4 Pharmaceuticals Completes Merger with Arsanis
March 13, 2019
Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment...
May 17, 2019
Novartis Poaches GSK Veteran as New Sandoz CEO
April 24, 2019
Merrimack Discontinues Development of MM-310
April 4, 2019
Load more
HOT NEWS
Financial
Alexion to Report First Quarter Results on Thursday, April 25, 2019
Phase III
AKL Research & Development and Nordic Bioscience Collaborate to Take Novel...
Phase II
First Sublingual Ketamine Drug for Treatment of Acute Pain to be...
Others
Bayer and Foundation Medicine announce global collaboration to develop next-generation sequencing...
